ALEXANDRIA, Va., June 6 -- United States Patent no. 12,281,084, issued on April 22, was assigned to The Wistar Institute (Philadelphia).

"Acetyl-CoA synthetase 2 (ACSS2) inhibitors and methods using same" was invented by Zachary Schug (Philadelphia), Joseph Salvino (Philadelphia) and Valli Venkata Srikanth Yellamelli (Philadelphia).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides compounds, which in certain embodiments are ACSS2 inhibitors. In certain embodiments, the compounds of the disclosure are useful for treating, ameliorating, and/or preventing certain types of cancer."

The patent was filed on June 12, 2020, under Application No. 17/618,397.

*For further information, inc...